B-cell lymphoma unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma

被引:0
|
作者
Savas, Zorzos C. [1 ]
Hatzianastassiou, D. [1 ]
Anagnostakis, D. [1 ]
Papadaki, T. [1 ]
Androulaki, A. [1 ]
机构
[1] Elpis Gen Hosp, Athens, Attika, Greece
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:258 / 258
页数:1
相关论文
共 50 条
  • [41] GRAY ZONE LYMPHOMA WITH FEATURES INTERMEDIATE BETWEEN DIFFUSE LARGE B-CELL LYMPHOMA AND CLASSICAL HODGKIN LYMPHOMA: DIAGNOSTIC EXPERIENCES AND CHALLENGES FROM A MULTICENTER STUDY
    Pilichowska, M.
    Pittaluga, S.
    Ferry, J. A.
    Hemminger, J.
    Gupta, G.
    Kritharis, A.
    Gascoyne, R. D.
    Evens, A. M.
    Jaffe, E. S.
    HAEMATOLOGICA, 2016, 101 : 21 - 22
  • [42] Clinical Features and Treatment Outcomes of Grey Zone Lymphoma (GZL), Unclassifiable B- Cell Lymphoma with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma - a Real-Life Multicenter Study By the Croatian Cooperative Group for Hematologic Diseases (KroHem)
    Hude, Ida
    Brcic, Klara
    Peric, Martina Moric
    Milunovic, Vibor
    Vujcic, Milan
    Krecak, Ivan
    Mitrovic, Zdravko
    Coha, Bozena
    Gasparov, Slavko
    Dotlic, Snjezana
    Ilic, Ivana
    Basic-Kinda, Sandra
    Aurer, Igor
    Rincic, Goran
    BLOOD, 2023, 142
  • [43] IGH amplification in patients with B cell lymphoma unclassifiable, with features intermediate between diffuse large B cell lymphoma and Burkitt's lymphoma
    Bellone M.
    Zaslav A.-L.
    Ahmed T.
    Lee H.L.
    Ma Y.
    Hu Y.
    Biomarker Research, 2 (1)
  • [44] Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort
    Evens, Andrew M.
    Kanakry, Jennifer A.
    Sehn, Laurie H.
    Kritharis, Athena
    Feldman, Tatyana
    Kroll, Aimee
    Gascoyne, Randy D.
    Abramson, Jeremy S.
    Petrich, Adam M.
    Hernandez-Ilizaliturri, Francisco J.
    Al-Mansour, Zeina
    Adeimy, Camille
    Hemminger, Jessica
    Bartlett, Nancy L.
    Mato, Anthony
    Caimi, Paolo F.
    Advani, Ranjana H.
    Klein, Andreas K.
    Nabhan, Chadi
    Smith, Sonali M.
    Fabregas, Jesus C.
    Lossos, Izidore S.
    Press, Oliver W.
    Fenske, Timothy S.
    Friedberg, Jonathan W.
    Vose, Julie M.
    Blum, Kristie A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (09) : 778 - 783
  • [45] Gray Zone Lymphoma (GZL) with Features Intermediate Between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of Tumor Immunophenotype (IP) and Critical Examination of Therapy with Associated Impact on Outcome
    Kritharis, Athena
    Kanakry, Jennifer A.
    Sehn, Laurie H.
    Feldman, Tatyana
    Kroll, Aimee
    Gascoyne, Randy D.
    Petrich, Adam M.
    Abramson, Jeremy S.
    Hernandez-Ilizaliturri, Francisco
    Al-Mansour, Zeina
    Adeimy, Camille
    Hemminger, Jessica
    Bartlett, Nancy L.
    Mato, Anthony R.
    Caimi, Paolo
    Advani, Ranjana
    Klein, Andreas K.
    Lossos, Izidore S.
    Press, Oliver W.
    Smith, Sonali M.
    Fabregas, Jesus C.
    Nabhan, Chadi
    Fenske, Timothy S.
    Friedberg, Jonathan W.
    Vose, Julie M.
    Blum, Kristie A.
    Evens, Andrew M.
    BLOOD, 2014, 124 (21)
  • [46] Spinal cord compression by B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in a patient seropositive for human immunodeficiency virus: A case report
    Seo J.-Y.
    Ha K.-Y.
    Kim M.-U.
    Kim Y.-C.
    Kim Y.-H.
    Journal of Medical Case Reports, 8 (1)
  • [47] BURKITT-LYMPHOMA AND BURKITT-LIKE LYMPHOMA/B-CELL LYMPHOMA UNCLASSIFIABLE WITH FEATURES INTERMEDIATE BETWEEN DIFFUSE LARGE B-CELL LYMPHOMA AND BURKITT LYMPHOMA: CLINICO-PATHOLOGICAL FEATURES AND SURVIVAL FROM AN ACADEMIC HOSPITAL IN CAPE TOWN
    Koller, Ania
    Antel, Katherine
    Novitzky, Nicolas
    Opie, Jessica
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 : 92 - 92
  • [48] Transition Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma- Our Histopathological and Clinical Experience With Patients With Intermediate Lymphoma
    Simon, Zsofia
    Virga, Balint
    Pinczes, Laszlo
    Mehes, Gabor
    Miltenyi, Zsofia
    Barna, Sandor
    Szabo, Roxana
    Illes, Arpad
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [49] Gray Zone Lymphoma (GZL) With Features Intermediate Between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective Multicenter Analysis Of Clinical Characteristics, Treatment, Outcomes, and Prognosis In The Current Era
    Evens, Andrew M.
    Kanakry, Jennifer A.
    Sehn, Laurie H.
    Feldman, Tatyana
    Kroll, Aimee
    Gascoyne, Randy D.
    Petrich, Adam M.
    Abramson, Jeremy S.
    Hernandez-Ilizaliturri, Francisco J.
    Al-Mansour, Zeina
    Adeimy, Camille
    Hemminger, Jessica
    Bartlett, Nancy L.
    Mato, Anthony
    Caimi, Paolo F.
    Advani, Ranjana H.
    Klein, Andreas K.
    Lossos, Izidore S.
    Press, Oliver W.
    Friedberg, Jonathan W.
    Vose, Julie M.
    Blum, Kristie A.
    BLOOD, 2013, 122 (21)
  • [50] Clinicopathological Features and Prognosis of B-Cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma with t(14;18) and 8q24 Translocation in the Rituximab Era
    Niitsu, Nozomi
    Takahashi, Naoki
    Kohri, Mika
    Asou, Norio
    Tamaru, Jun-ichi
    Sakai, Jun
    Nakamura, Shigeo
    Miura, Ikuo
    Okamoto, Masataka
    BLOOD, 2014, 124 (21)